LncRNA ADAMTS9-AS1 inhibits the stemness of lung adenocarcinoma cells by regulating miR-5009-3p/NPNT axis

被引:9
作者
Wang, Ping [1 ,2 ]
Zhang, Yanli [1 ,2 ]
Lv, Xiaodong [2 ]
Zhou, Jian [1 ,2 ]
Cang, Shundong [3 ]
Song, Yongping [1 ,2 ]
机构
[1] Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China
[2] Henan Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Canc Hosp, Cent Lab, Zhengzhou 450008, Henan, Peoples R China
关键词
Cancer stem cell; Stemness; Lung adenocarcinoma; Colony formation; miR-5009-3p; PROLIFERATION; CANCER; PROGRESSION; MIGRATION; INVASION; EMT;
D O I
10.1016/j.ygeno.2023.110596
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We sought to extend our observation of LncRNA ADAMTS9-AS1 and to specifically uncover its role on the stemness of lung adenocarcinoma (LUAD) cancer cells. ADAMTS9-AS1 was poorly expressed in LUAD. The high ADAMTS9-AS1 expression was positively associated with overall survival. ADAMTS9-AS1 overexpression attenuated the colony-forming capacity and reduced stem cell-like population of LUAD cancer stem cells (CSCs). Furthermore, ADAMTS9-AS1 overexpression increased E-cadherin expression in addition to the downregulated expressions of Fibronectin and Vimentin in LUAD spheres. In vitro results also confirmed the ADAMTS9-AS1's inhibitory effect on the growth of LUAD cells. Moreover, the antagonistic repression of miR-5009-3p levels with the expression of ADAMTS9-AS1 and NPNT was confirmed. Finally, ADAMTS9-AS1 overexpression curbed the increasing stemness of LUDA-CSC caused by NPNT silencing, thus leading to the suppression of LUAD progression in vitro. Conclusively, ADAMTS9-AS1 negatively controls the LUAD cancer cell stemness progression through regulating miR-5009-3p/NPNT axis.
引用
收藏
页数:11
相关论文
共 31 条
[1]   LNCcation: lncRNA localization and function [J].
Bridges, Mary Catherine ;
Daulagala, Amanda C. ;
Kourtidis, Antonis .
JOURNAL OF CELL BIOLOGY, 2021, 220 (02)
[2]   LncRNA ADAMTS9-AS1, as prognostic marker, promotes cell proliferation and EMT in colorectal cancer [J].
Chen, Wanjing ;
Tu, Qian ;
Yu, Liang ;
Xu, Yanyan ;
Yu, Gang ;
Jia, Benli ;
Cheng, Yunsheng ;
Wang, Yong .
HUMAN CELL, 2020, 33 (04) :1133-1141
[3]   LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p [J].
Dong, Hui-Xing ;
Wang, Ren ;
Jin, Xiao-Yan ;
Zeng, Jian ;
Pan, Jing .
JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (05) :4126-4136
[4]   LncRNA ADAMTS9-ASI Restrains the Aggressive Traits of Breast Carcinoma Cells via Sponging miR-513a-5p [J].
Fang, Shiqiang ;
Zhao, Yu ;
Hu, Xiaozhen .
CANCER MANAGEMENT AND RESEARCH, 2020, 12 :10693-10703
[5]   Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis [J].
Han, Pihua ;
Yang, Haiming ;
Li, Xiang ;
Wu, Jie ;
Wang, Peili ;
Liu, Dapeng ;
Xiao, Guodong ;
Sun, Xin ;
Ren, Hong .
ONCOLOGY RESEARCH, 2020, 28 (7-8) :715-729
[6]   LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis [J].
Hua, Qian ;
Jin, Mingming ;
Mi, Baoming ;
Xu, Fei ;
Li, Tian ;
Zhao, Li ;
Liu, Jianjun ;
Huang, Gang .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
[7]   Spectrum of Lung Adenocarcinoma [J].
Hutchinson, Barry D. ;
Shroff, Girish S. ;
Truong, Mylene T. ;
Ko, Jane P. .
SEMINARS IN ULTRASOUND CT AND MRI, 2019, 40 (03) :255-264
[8]   CircCRIM1 Promotes Hepatocellular Carcinoma Proliferation and Angiogenesis by Sponging miR-378a-3p and Regulating SKP2 Expression [J].
Ji, Yang ;
Yang, Shikun ;
Yan, Xueqi ;
Zhu, Li ;
Yang, Wenjie ;
Yang, Xinchen ;
Yu, Fei ;
Shi, Longqing ;
Zhu, Xi ;
Lu, Yunjie ;
Zhang, Chuanyong ;
Lu, Hao ;
Zhang, Feng .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[9]   Dickkopf-related protein 3 promotes cell adhesion and invasion during progression of lung adenocarcinoma [J].
Komori, Yuka ;
Kano, Junko ;
Nakano, Noriyuki ;
Sakashita, Shingo ;
Sakamoto, Noriaki ;
Noguchi, Masayuki .
PATHOLOGY INTERNATIONAL, 2019, 69 (11) :646-654
[10]   MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma [J].
Li, Dong ;
Wang, Tao ;
Sun, Fei-Fan ;
Feng, Jian-Qiong ;
Peng, Jing-Jing ;
Li, Hua ;
Wang, Chao ;
Wang, Dan ;
Liu, Yu ;
Bai, Yu-Di ;
Shi, Mao-Lin ;
Zhang, Tao .
CANCER GENE THERAPY, 2021, 28 (1-2) :126-140